TW
Thane Wettig
CEO

Thane Wettig insider trades: Kyntra Bio (KYNB) stock buys and sales

CEO, Kyntra Bio Last trade May 14, 2026 48 Form 4 filings
$0
Sold, last 12 months
0 sales
$54K
Bought, last 12 months
2 buys
11
Open-market trades
since 2021
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thane reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 14, 2026KYNB↑ Buy$20K
Nov 17, 2025FGEN↑ Buy$34K
Mar 24, 2025FGEN↑ Buy$51K
Mar 7, 2024FGEN↑ Buy$95K
Jun 23, 2023FGEN↓ Sell$13K
Jun 7, 2023FGEN↓ Sell$30K
Mar 23, 2023FGEN↓ Sell$17K
Mar 10, 2023FGEN↓ Sell$287K
Dec 23, 2022FGEN↓ Sell$12K
Dec 8, 2022FGEN↓ Sell$6K
Aug 26, 2021FGEN↑ Buy$36K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thane Wettig's insider trades

Thane Wettig is CEO at Kyntra Bio (KYNB). Since Aug 26, 2021, Thane has reported 5 open-market purchases worth $235K and 6 sales worth $365K on SEC Form 4. In the last 12 months: 2 buys ($54K).

Their filings also include shares withheld for taxes (28 filings), grants and awards (11 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYNB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.